ALAP-1 for the attenuation of nasal provocation with histamine in seasonal allergic rhinitis: a randomised, double-blind, placebo-controlled, three-day dosing, cross-over study and dose finding one month cross-over study

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2008
This article has no abstract
Epistemonikos ID: 57e99206ddc3c8b2204afffd72aee5a1d593441a
First added on: Oct 16, 2021